Back to 
RHUMBLINE ADVISERS
RHUMBLINE ADVISERS
DICEShowing 0 of 8 quarters
Position history for RHUMBLINE ADVISERS's holdings in DICE THERAPEUTICS INC
As of its Q2 2023 13F, RhumbLine Advisers held 53,286 shares of DICE (Dice Therapeutics), worth $2.5M. RhumbLine Advisers' 13F filings listed DICE from Q4 2021 to Q2 2023, 7 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of DICE: RA CAPITAL MANAGEMENT, L.P., FMR LLC